Yellow Fever Vaccination of a Primary Vaccinee During Adalimumab Therapy

E-ISSN： 1708-8305|22|4|279-281

ISSN： 1195-1982

Source： JOURNAL OF TRAVEL MEDICINE, Vol.22, Iss.4, 2015-07, pp. : 279-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No Booster Dose for Yellow Fever Vaccination: What Are the Consequences for the Activity of Vaccination in Travel Clinics?

JOURNAL OF TRAVEL MEDICINE, Vol. 22, Iss. 2, 2015-03 ,pp. : 140-141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lessons learnt from the management of a case of Lassa fever and follow‐up of nosocomial primary contacts in Nigeria during Ebola virus disease outbreak in West Africa

TROPICAL MEDICINE & INTERNATIONAL HEALTH, Vol. 1360-2276, Iss. 11, 2015-11 ,pp. : 1424-1430

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lessons learnt from the management of a case of Lassa fever and follow‐up of nosocomial primary contacts in Nigeria during Ebola virus disease outbreak in West Africa

TROPICAL MEDICINE & INTERNATIONAL HEALTH, Vol. 20, Iss. 11, 2015-11 ,pp. : 1424-1430

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidemiology, Immunology, and Yellow Fever: The Rockefeller Foundation in Brazil, 1923–1939

By Löwy I.

Journal of the History of Biology, Vol. 30, Iss. 3, 1997-01 ,pp. : 397-417

Springer Publishing Company

Access to resources Recommend Favorite

Gene therapy for primary immunodeficiencies

CLINICAL GENETICS, Vol. 88, Iss. 6, 2015-12 ,pp. : 507-515

John Wiley & Sons Inc

Access to resources Recommend Favorite